Triomics raises a $22.0M Series B round

Triomics builds oncology-specific AI for cancer centers, automating chart prep, clinical trial matching, and tumor registry reporting against complex multi-year patient records. The platform is used by academic centers including Memorial Sloan Kettering and Yale Cancer Center, and is positioned against generic AI scribes by training models on oncology data rather than general clinical text.